Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Colorectal Neoplasms

Free Subscription 23.01.2012 2 Am J Clin Oncol 1 BMC Cancer 2 Br J Cancer 1 Cancer Lett 1 Clin Med Insights Oncol 1 Eur J Cancer 1 Gastroenterology 2 Gut 1 Int J Colorectal Dis 1 Int J Oncol 4 J Clin Oncol 2 J Surg Oncol 1 Lancet Oncol 2 Oncol Rep 1 Oncology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. CHUA TC , Liauw W, Chu F, Morris DL, et al
   Viewing metastatic colorectal cancer as a curable chronic disease.
   Am J Clin Oncol. 2012;35:77-80.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CHALKIAS A , Nikotian G, Koutsovasilis A, Bramis J, et al
   Patients with colorectal cancer are characterized by increased concentration of fecal hb-hp complex, myeloperoxidase, and secretory IgA.
   Am J Clin Oncol. 2011;34:561-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   BMC Cancer

3. LANG AH , Geller-Rhomberg S, Winder T, Stark N, et al
   A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients.
   BMC Cancer. 2012;12:20.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Br J Cancer

4. SOUGLAKOS J , Ziras N, Kakolyris S, Boukovinas I, et al
   Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC).
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. DOTAN E , Meropol NJ, Zhu F, Zambito F, et al
   Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer.
   Br J Cancer. 2012 Jan 12. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Lett

6. LAMPROPOULOS P , Zizi-Sermpetzoglou A, Rizos S, Kostakis A, et al
   TGF-beta signalling in colon carcinogenesis.
   Cancer Lett. 2012;314:1-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Clin Med Insights Oncol

7. WANG TF , Lockhart AC
   Aflibercept in the treatment of metastatic colorectal cancer.
   Clin Med Insights Oncol. 2012;6:19-30.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Eur J Cancer

8. HUIDOBRO C , Urdinguio RG, Rodriguez RM, Mangas C, et al
   A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in human colorectal cancer.
   Eur J Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Gastroenterology

9. ALMEIDA MI , Nicoloso MS, Zeng L, Ivan C, et al
   Strand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells.
   Gastroenterology. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Gut

10. CHUNG SJ , Kim YS, Yang SY, Song JH, et al
    Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.
    Gut. 2011;60:1537-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. JUBB AM , Hoeflich KP, Haverty PM, Wang J, et al
    Ascl2 and 11p15.5 amplification in colorectal cancer.
    Gut. 2011;60:1606-7.
    PubMed     Text format     Related articles   
    
    
    

    
    Int J Colorectal Dis

12. PLASCHKE J , Preussler M, Ziegler A, Schackert HK, et al
    Aberrant protein expression and frequent allelic loss of MSH3 in colorectal cancer with low-level microsatellite instability.
    Int J Colorectal Dis. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Int J Oncol

13. MIYAKE M , Takemasa I, Matoba R, Tanino M, et al
    Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis.
    Int J Oncol. 2011;39:781-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Clin Oncol

14. HURWITZ HI , Lyman GH
    Registries and Randomized Trials in Assessing the Effects of Bevacizumab in Colorectal Cancer: Is There a Common Theme?
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles   
    
    
    
15. MEYERHARDT JA , Li L, Sanoff HK, Carpenter W 4th, et al
    Effectiveness of Bevacizumab With First-Line Combination Chemotherapy for Medicare Patients With Stage IV Colorectal Cancer.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. GOVINDARAJAN A , Gonen M, Weiser MR, Shia J, et al
    Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy.
    J Clin Oncol. 2011;29:4568-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. PATEL UB , Taylor F, Blomqvist L, George C, et al
    Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience.
    J Clin Oncol. 2011;29:3753-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Surg Oncol

18. ROSSI DEL MONTE S , Ranieri D, Mazzetta F, Kazemi Nava A, et al
    Free peritoneal tumor cells detection in gastric and colorectal cancer patients.
    J Surg Oncol. 2012 Jan 18. doi: 10.1002/jso.23052.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HYSLOP T , Weinberg DS, Schulz S, Barkun A, et al
    Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer.
    J Surg Oncol. 2012 Jan 17. doi: 10.1002/jso.23051.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Lancet Oncol

20. ROUSSEAU P
    Till death do us part.
    Lancet Oncol. 2011;12:1192-3.
    PubMed     Text format     Related articles   
    
    
    

    
    Oncol Rep

21. OHKUBO H , Takahashi H, Yamada E, Sakai E, et al
    Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
    Oncol Rep. 2012 Jan 12. doi: 10.3892/or.2012.1631.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. BARNI MV , Carlini MJ, Cafferata EG, Puricelli L, et al
    Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells.
    Oncol Rep. 2012 Jan 11. doi: 10.3892/or.2012.1630.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Oncology

23. KONIGSBERG R , Hulla W, Klimpfinger M, Reiner-Concin A, et al
    Clinical and Economic Aspects of KRAS Mutational Status as Predictor for Epidermal Growth Factor Receptor Inhibitor Therapy in Metastatic Colorectal Cancer Patients.
    Oncology. 2012;81.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: